Worth reading
80Important
Scored from 4 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
52
億円(2023年営業利益予想の前年差減少)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings report2022年12月期 通期(2022年通期実績・2023年通期業績予想)8 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥14,504 100 million+14.3%
Operating profit¥1,397 100 million+17.8%
Ordinary income¥1,393 100 million +19.0%profit before tax
Net income¥823 100 million +19.9%profit for the year attributable to owners of the parent
Selling, general and administrative expenses¥4,202 100 million
Gross Profit Margin
Rate38.1%
Year-on-year change (points)△3.1ポイント
Operating profit margin
Rate9.6%
Year-on-year change (points)+0.3 percentage points
Full-year earnings forecast
Revenue
¥15,315 100 million
Operating profit
¥1,345 100 million
Income before taxes
¥1,335 100 million
Profit for the period attributable to owners of the parent
¥755 100 million
EBITDA
¥2,080 100 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Segment profit of the Japan business
2021年セグメント利益409
売上収益増減236
Changes in cost of sales-307
Change in sales promotion and advertising expenses-4
Other1
2022年セグメント利益334
2023年日本事業セグメント利益予想
2022年セグメント利益334
売上収益増減353
Changes in cost of sales-285
Change in sales promotion and advertising expenses-37
Other-31
2023年セグメント利益予想334
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
US dollars130
Euro141
British pound160
Singapore dollars98
Thai baht3.9
Vietnamese dong0.01
ニュージーランドドル84
Australian dollar91
New initiatives
- 組織変更に伴い、アフリカ事業をアジアパシフィック事業から欧州事業へ組み替えて表示
Key KPIsA metric the company considers important as a management benchmark.
- EBITDA¥2,026 100 millionYear on year against the same period last year+3.9%
- EBITDA margin14 %Year on year against the same period last year-1.4 percentage points
- EPS¥266.4Year on year against the same period last year+19.9%
- ROE9 %Year on year against the same period last year+0.6 percentage points
- Dividend payout ratio30 %Year on year against the same period last year△5.1ポイント
- Total sales volume in the Japan business444.7 million casesYear on year against the same period last year+6.0%
- 特定保健用食品および機能性表示食品販売数量32.6 million casesYear on year against the same period last year+62.0%
Segment results
Japan
Revenue
¥6,532 100 million+3.7%
EBITDA
¥683 100 million-12.0%
Segment profit
¥334 100 million-18.4%
Asia Pacific
Revenue
¥3,594 100 million+21.4%
EBITDA
¥628 100 million+12.2%
Segment profit
¥564 100 million+42.0%
Europe
Revenue
¥2,923 100 million+24.5%
EBITDA
¥565 100 million+9.3%
Segment profit
¥434 100 million+21.5%
Americas
Revenue
¥1,455 100 million+34.1%
EBITDA
¥238 100 million+34.4%
Segment profit
¥182 100 million+36.6%
Financial targets
ROE
2022年実績9 %
2023年予想7.5 %
Debt-to-equity ratio
2022年実績-0.03 times
2023年予想-0.04 times
Capital expenditures
¥654 100 million
Payout ratio
Rate30 %
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | 2022年12月期 通期(2022年通期実績・2023年通期業績予想) |
| Net Sales | ¥14,504 100 million (YoY +14.3%) |
| Operating profit | ¥1,397 100 million (YoY +17.8%) |
| Ordinary income | ¥1,393 100 million (profit before tax) (YoY +19.0%) |
| Net income | ¥823 100 million (profit for the year attributable to owners of the parent) (YoY +19.9%) |
| Gross Profit Margin | Rate 38.1% / Year-on-year change (points) △3.1ポイント |
| Operating profit margin | Rate 9.6% / Year-on-year change (points) +0.3 percentage points |
| Selling, general and administrative expenses | ¥4,202 100 million |
| Full-year earnings forecast | Revenue ¥15,315 100 million / Operating profit ¥1,345 100 million / Income before taxes ¥1,335 100 million / Profit for the period attributable to owners of the parent ¥755 100 million / EBITDA ¥2,080 100 million |
| Segment results | Japan Revenue ¥6,532 100 million (YoY +3.7%) / EBITDA ¥683 100 million (YoY -12.0%) / Segment profit ¥334 100 million (YoY -18.4%) / Asia Pacific Revenue ¥3,594 100 million (YoY +21.4%) / EBITDA ¥628 100 million (YoY +12.2%) / Segment profit ¥564 100 million (YoY +42.0%) / Europe Revenue ¥2,923 100 million (YoY +24.5%) / EBITDA ¥565 100 million (YoY +9.3%) / Segment profit ¥434 100 million (YoY +21.5%) / Americas Revenue ¥1,455 100 million (YoY +34.1%) / EBITDA ¥238 100 million (YoY +34.4%) / Segment profit ¥182 100 million (YoY +36.6%) |
| Breakdown of Factors Affecting the Change | Segment profit of the Japan business 2021年セグメント利益 409 / 売上収益増減 236 / Changes in cost of sales -307 / Change in sales promotion and advertising expenses -4 / Other 1 / 2022年セグメント利益 334 / 2023年日本事業セグメント利益予想 2022年セグメント利益 334 / 売上収益増減 353 / Changes in cost of sales -285 / Change in sales promotion and advertising expenses -37 / Other -31 / 2023年セグメント利益予想 334 |
| Key KPIs | Indicator name EBITDA / Value ¥2,026 100 million / Year on year against the same period last year ¥3.9 100 million, Indicator name EBITDA margin / Value 14 % / Year on year against the same period last year -1.4 percentage points, Indicator name EPS / Value ¥266.4 / Year on year against the same period last year ¥19.9, Indicator name ROE / Value 9 % / Year on year against the same period last year +0.6 percentage points, Indicator name Dividend payout ratio / Value 30 % / Year on year against the same period last year △5.1ポイント, Indicator name Total sales volume in the Japan business / Value 444.7 million cases / Year on year against the same period last year 6 million cases, Indicator name 特定保健用食品および機能性表示食品販売数量 / Value 32.6 million cases / Year on year against the same period last year 62 million cases |
| Assumptions Underlying the Business Outlook | Exchange rate US dollars 130 / Euro 141 / British pound 160 / Singapore dollars 98 / Thai baht 3.9 / Vietnamese dong 0.01 / ニュージーランドドル 84 / Australian dollar 91 |
| Financial targets | ROE 2022年実績 9 % / 2023年予想 7.5 % / Debt-to-equity ratio 2022年実績 -0.03 times / 2023年予想 -0.04 times |
| Payout ratio | Rate 30 % |
| Capital expenditures | ¥654 100 million |
| New initiatives | 組織変更に伴い、アフリカ事業をアジアパシフィック事業から欧州事業へ組み替えて表示 |
Items this document does not state (13)
Results for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.2022年の日本事業では、売上収益の増加があった一方、原価が307億円増加したため、セグメント利益が75億円減少した。2023年予想では、日本事業について売上収益増加353億円に対し、原価285億円増加、販売促進費・広告宣伝費37億円増加、その他31億円減少を見込んでいる。なお、2023年からアフリカ事業をアジアパシフィック事業から欧州事業へ組み替えて表示している。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.